Jubilant Ingrevia rises on commissioning new facility for Diketene derivatives in Uttar Pradesh
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Jubilant Ingrevia is currently trading at Rs. 456.60, up by 4.90 points or 1.08% from its previous closing of Rs. 451.70 on the BSE.
The scrip opened at Rs. 454.25 and has touched a high and low of Rs. 466.15 and Rs. 454.25 respectively. So far 2422 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 524.50 on 07-Sep-2023 and a 52 week low of Rs. 357.00 on 31-Mar-2023.
Last one week high and low of the scrip stood at Rs. 466.15 and Rs. 440.50 respectively. The current market cap of the company is Rs. 7194.73 crore.
The promoters holding in the company stood at 51.47%, while Institutions and Non-Institutions held 17.53% and 30.99% respectively.
Jubilant Ingrevia has commissioned a new facility at its manufacturing site for Diketene derivatives at Gajraula, Uttar Pradesh. As a global, integrated life science products and innovative solutions provider, the company presently has over 134 products & innovative solutions commercialised. With over four decades of experience, it has developed proficiency across around 35 key chemistry and technology platforms across its businesses: Specialty, Nutrition and Chemical Intermediates.
The newly commissioned facility adds additional capacity of 2,000 TPA to produce high-value esters. This strengthening of the Diketene and derivatives platform marks a natural evolution of strategy in the Specialty Chemicals segment. This business is pivoting towards accelerated growth and higher margins with the introduction of several downstream derivatives.
In line with its long-term strategic objectives, Jubilant Ingrevia remains committed to commissioning of future phases of Diketene derivatives. In addition to existing clients the expanded range of diketene derivatives will be aimed at a new category of customers in key international markets, including the U.S and E.U regions.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
